Department of Endodontics, Shanxi Medical University School and Hospital of Stomatology, Taiyuan, Shanxi, China.
Central Laboratory, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, China.
J Nanobiotechnology. 2024 Aug 24;22(1):508. doi: 10.1186/s12951-024-02752-6.
Regenerating inflamed bone defects represents a severe clinical challenge due to the undesirable inflammatory microenvironment. The inflammatory stimulus poses a weighty threat to the regenerative capacity of endogenously derived mesenchymal stem cells (MSCs), which are mainly responsible for osteogenic differentiation, thereby resulting in compromised endogenous bone formation. Consequently, alleviating the biological characteristics of inflammatory-impaired MSCs is crucial for promoting inflamed bone regeneration. Nano-sized small extracellular vesicles (sEVs) have emerged as promising therapeutic tools to orchestrate MSCs fate due to their intrinsic biocompatibility and encapsulated bioactive contents. In the present study, we extracted sEVs from youthful and adult dental pulp MSCs and explored their ability to recover inflammation-compromised periodontal ligament stem cells (IPDLSCs). The results indicated that both types of sEVs were capable of facilitating IPDLSCs osteogenesis. However, young sEVs exhibited a more robust potential at a lower concentration compared to adult sEVs. Mechanically, young sEVs enhanced the expression of bone morphogenetic protein 4 (BMP4) via delivering the protein Biglycan, which correspondingly promoted the osteogenic capability of IPDLSCs. Collectively, our findings emphasized that young sEVs hold enormous potential to rescue the inherent function and regenerative competence of inflammation-impaired MSCs, shedding light on their promising therapeutic prospects for infected bone regeneration.
再生炎症性骨缺损是一个严重的临床挑战,因为炎症微环境不理想。炎症刺激对主要负责成骨分化的内源性间充质干细胞(MSCs)的再生能力构成了严重威胁,导致内源性骨形成受损。因此,减轻炎症损伤的 MSCs 的生物学特性对于促进炎症性骨再生至关重要。由于纳米级小细胞外囊泡(sEVs)具有内在的生物相容性和封装的生物活性内容,因此成为一种有前途的调节 MSCs 命运的治疗工具。在本研究中,我们从年轻和成年牙髓 MSC 中提取 sEVs,并探索它们恢复炎症损伤的牙周韧带干细胞(IPDLSCs)的能力。结果表明,两种类型的 sEVs 都能够促进 IPDLSCs 的成骨作用。然而,与成年 sEVs 相比,年轻 sEVs 在较低浓度下表现出更强的潜力。从机制上讲,年轻的 sEVs 通过递送蛋白聚糖来增强骨形态发生蛋白 4(BMP4)的表达,从而相应地促进了 IPDLSCs 的成骨能力。总之,我们的研究结果强调了年轻 sEVs 具有巨大的潜力来挽救炎症损伤的 MSCs 的固有功能和再生能力,为感染性骨再生的治疗前景提供了新的思路。